Literature DB >> 32497414

Animal Models of Mycobacteria Infection.

Edward D Chan1, Deepshikha Verma2, Diane J Ordway2.   

Abstract

This manuscript describes the infection of mice and guinea pigs with mycobacteria via various routes, as well as necropsy methods for the determination of mycobacterial loads within target organs. Additionally, methods for cultivating mycobacteria and preparing stocks are described. The protocols outlined are primarily used for M. tuberculosis, but can also be used for the study of other non-tuberculosis mycobacterial species. A wide variety of animal models have been used to test new vaccines, drugs, and the impact of cigarette exposure.
© 2020 Wiley Periodicals LLC. Basic Protocol 1: Aerosol infection of mice with mycobacteria Basic Protocol 2: Aerosol infection of guinea pig with mycobacteria using a Madison chamber Alternate Protocol 1: Cigarette exposure prior to infection of mice with mycobacteria Alternate Protocol 2: Intravenous infection of mice with mycobacteria Basic Protocol 3: Necropsy methods for animals experimentally infected with mycobacteria Basic Protocol 4: Following the course of infection Basic Protocol 5: Measuring the animal immune response to infection Support Protocol: Cultivation of mycobacteria for use in animal experiments. © 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  animal models; guinea pig; inhalation exposure system; mouse; mycobacteria; necropsy; tuberculosis

Year:  2020        PMID: 32497414     DOI: 10.1002/cpim.98

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  4 in total

Review 1.  One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics.

Authors:  Hee-Jeong Yang; Decheng Wang; Xin Wen; Danielle M Weiner; Laura E Via
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

2.  Efficacy and immunogenicity of different BCG doses in BALB/c and CB6F1 mice when challenged with H37Rv or Beijing HN878.

Authors:  Bhagwati Khatri; James Keeble; Belinda Dagg; Daryan A Kaveh; Philip J Hogarth; Mei Mei Ho
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.996

3.  CD84 is a Suppressor of T and B Cell Activation during Mycobacterium tuberculosis Pathogenesis.

Authors:  Nan Zheng; Joy Fleming; Peilei Hu; Jianjian Jiao; Guoqin Zhang; Ruifang Yang; Chuanyou Li; Yi Liu; Lijun Bi; Hongtai Zhang
Journal:  Microbiol Spectr       Date:  2022-02-23

Review 4.  Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.

Authors:  Deepshikha Verma; Edward D Chan; Diane J Ordway
Journal:  Vaccines (Basel)       Date:  2020-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.